ID   COG-N-452
AC   CVCL_VS96
DR   Wikidata; Q93456545
RX   PubMed=28340497;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 12
ST   D18S51: 15,17
ST   D19S433: 12,16
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 18,22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LF59 ! COG-N-453
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
RX   PubMed=28340497; DOI=10.1002/ijc.30706;
RA   Lopez-Barcons L., Maurer B.J., Kang M.H., Reynolds C.P.;
RT   "P450 inhibitor ketoconazole increased the intratumor drug levels and
RT   antitumor activity of fenretinide in human neuroblastoma xenograft
RT   models.";
RL   Int. J. Cancer 141:405-413(2017).
//